'); } -->
Corporate pledges of new jobs have become almost routine in much of North Carolina this year.
But none was as big as the 1,100-employee announcement Wednesday from a small, privately held Raleigh drug researcher.
INC Research, which moved from San Diego to leased offices in North Raleigh seven years ago, said it plans to invest $19.2 million in a growth spurt that would include new corporate headquarters in Wake County by 2011.
1996 INC Research is founded in San Diego.
1998 Work on contract drug research begins.
2000 Headquarters moves from San Diego to Raleigh; employs about 50.
2002 INC leases sixth floor of office building at 4700 Falls of Neuse Road that accommodates about 250 employees.
2006 INC buys Pharmaceutical Resource Corp., a suburban Philadelphia market research company that employs about 20.
APRIL 2007 INC buys Advanced Biologics, a suburban Philadelphia company that specializes in helping drug makers develop infectious-disease treatments. The deal increases INC's payroll to 900 worldwide and 400 in Raleigh.
JULY 2007 INC leases fifth floor in the building adjacent to the headquarters, doubling available space to 58,000 square feet.
OCTOBER 2007 INC announces it will add nearly 1,100 jobs at its Raleigh headquarters within four years.
About half a dozen companies have each announced intentions to create at least 200 jobs in the state this year, including Quintiles Transnational in Durham, which, like INC, is in the business of running tests for drug developers.
INC employs 1,300 people worldwide, including about 400 in Raleigh. It will be eligible for up to $14.8 million in state incentive grants if it meets hiring goals.
"This is good news for this county, this state, and we're excited about it," Gov. Mike Easley said at a news conference with INC executives. "It strengthens North Carolina's hold on biotechnology."
INC is the third contract research organization to announce a significant expansion in the Triangle this year. Together, PRA International of Raleigh, Quintiles and INC expect to create 2,500 jobs in the next few years.
The Triangle is benefiting from a boom in contract research organizations. Analysts predict that revenue in the industry will grow at least 15 percent this year and continue to gain momentum in years to come.
Stricter regulatory requirements, growing research and development budgets and drug makers' increasing reliance on the outsourcing of clinical trials are fueling the good times, said David Windley, an analyst for Jefferies.
"The industry is doing fantastically well," Windley said.
According to the N.C. Biotechnology Center, the state is home to 90 contract research organizations. Most of them are based in the Triangle or have operations here.
The region's trained labor pool and access to world-class academic and research facilities are appealing to the companies. The ability to recruit locally was one of the reasons INC picked Raleigh for its expansion, chief executive Jim Ogle said.
INC was also in talks with Philadelphia and Austin, Texas, Ogle said. Economic development recruiters in those states also offered incentives, he said, "but North Carolina did better."
As part of the agreement with the state, INC is required to create 984 jobs by 2011.
If INC fails to meet those terms, as well as other conditions, the grant could be reduced or terminated.
The jobs are expected to include management, research, data processing and administrative positions. Salaries are projected to average $62,690 per year, plus benefits.
(Staff writer Tim Simmons contributed to this report.)
Get it all with convenient home delivery of The News & Observer.
The News & Observer is pleased to be able to offer its users the opportunity to make comments and hold conversations online. However, the interactive nature of the internet makes it impracticable for our staff to monitor each and every posting.
Since The News & Observer does not control user submitted statements, we cannot promise that readers will not occasionally find offensive or inaccurate comments posted on our website. In addition, we remind anyone interested in making an online comment that responsibility for statements posted lies with the person submitting the comment, not The News and Observer.
If you find a comment offensive, clicking on the exclamation icon will flag the comment for review by the administrators, we are counting on the good judgment of all our readers to help us.